Search results for "Gout"
New cardiac warning for fluoroquinolones
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/02/new-cardiac-warning-for-fluoroquinolones.htm
1 Feb 2019
Boxed warning added to gout drug, more ARBs recalled
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/04/boxed-warning-added-to-gout-drug-more-arbs-recalled.htm
1 Apr 2019
Helping patients manage generic drug price increases
Generic drugs have recently become more expensive, from colchicine for gout to EpiPens for allergic reactions. Physicians are having trouble managing patients when their medicines suddenly rise in price.
https://immattersacp.org/archives/2019/09/helping-patients-manage-generic-drug-price-increases.htm
1 Sep 2019
Increasing help for physician impairment
This issue also covers new drugs for depression, conference coverage about gastroenterology, and escalating generic drug prices.
https://immattersacp.org/archives/2019/09/increasing-help-for-physician-impairment.htm
1 Sep 2019
Proposed warnings on cigarettes would be first in 35 years
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/10/proposed-warnings-on-cigarettes-would-be-first-in-35-years.htm
1 Oct 2019
MKSAP Quiz: Follow-up for primary membranous glomerulopathy
A 38-year-old woman is evaluated during a follow-up visit for primary membranous glomerulopathy diagnosed by kidney biopsy 4 months ago. She was found to be positive for anti–phospholipase A2 receptor (PLA2R) antibodies. Vital signs are normal and there is pitting lower extremity edema to the mid shins bilaterally. What complication is she at risk for developing?
https://immattersacp.org/weekly/archives/2019/11/05/3.htm
5 Nov 2019
SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists
In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
https://immattersacp.org/weekly/archives/2020/01/14/2.htm
14 Jan 2020
Guideline recommends allopurinol as first-line therapy for gout
The American College of Rheumatology noted that the drug is the preferred choice for urate-lowering therapy in all patients, including those with moderate to severe chronic kidney disease.
https://immattersacp.org/weekly/archives/2020/05/19/4.htm
19 May 2020
Need for hip, knee replacement appears reduced with canakinumab, industry-funded study finds
An editorial noted that a novel entry criterion may have identified a subgroup of patients with accelerated joint degeneration.
https://immattersacp.org/weekly/archives/2020/08/04/4.htm
4 Aug 2020
Keep a close eye on the kidneys in diabetes
Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020